Last reviewed · How we verify
NCT05980559
Evaluation of BTX Injections in Treatment of Bruxism
Phase 3 trial testing Xeomin in Bruxism in 12 participants. Status unknown.
15 January 2024
Quick facts
| Lead sponsor | Alexandria University |
|---|---|
| Phase | Phase 3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 15 January 2024 |
| Primary completion | 15 January 2024 |
| Estimated completion | 15 April 2024 |
Drugs / interventions tested
- Xeomin (INCOBOTULINUMTOXINA) — full drug profile →
Conditions studied
- Bruxism — all drugs for Bruxism →
Sponsor
Alexandria University
Who can join
Adults 20 to 60, any sex, with Bruxism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim of this study is to evaluate the effect of botulinum toxin type A (Xeomin®) on patients complaining from bruxism. The study will be a one arm clinical trial. Twelve subjects reporting bruxism irresponsive to conventional treatment modalities will be recruited and will be injected with botulinum toxin A (Xeomin®) in both masseter and temporalis muscles. Pain levels, Electromyographic activity and maximum occlusal force will be recorded in the subjects before injection and at 1 and 3 months after injection to determine the effect of treatment
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05980559
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Xeomin
Trials testing the same drug.
- NCT06995287 — Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysme · Phase 3 · recruiting
- NCT04102670 — Combination Therapy for Rejuvenation of the Lower Face and Neck · NA · unknown
- NCT03977493 — IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia · Phase 3 · recruiting
Other recruiting trials for Bruxism
Currently open trials in the same condition.
- NCT07452510 — Comparison of Dry Needling and Two Botulinum Toxins for Bruxism · NA · active not recruiting
- NCT07308145 — The Effect of Bruxism on Balance · recruiting
- NCT07241728 — Bruxism and Diadinamic Current · NA · recruiting
- NCT07109882 — Effectiveness of Chlorzoxazone Versus Orphenadrine Citrate in Alleviating Bruxism Pain · Phase 4 · recruiting
- NCT07090551 — Effect of Occlusal Splint on Head and Neck Muscles in Patients With Bruxism and Myofascial Pain · NA · recruiting
Other Alexandria University trials
Trials by the same sponsor.
- NCT07517861 — Integrated Mental Health Nursing Program: Effects on Stigma, Cognitive Flexibility, and Clinical Readiness · NA · recruiting
- NCT07476482 — The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delive · NA · enrolling by invitation
- NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
- NCT07503626 — Optimization of Orthodontic Bracket Placement by Using Two Different Protocols of Digitally Aided Bonding · NA · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05980559 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alexandria University
- Last refreshed: 5 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05980559.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing